Foundation Medicine, Inc. is a molecular diagnostics company focused on comprehensive genomic profiling (CGP) for cancer to help physicians match patients with targeted therapies, immunotherapies, and clinical trials. The company offers tissue- and liquid-based next-generation sequencing (NGS) tests and partners with biopharmaceutical companies to support oncology drug development and companion diagnostics. It operates as a wholly owned subsidiary of Roche.